0.00Open0.10Pre Close0 Volume14 Open Interest12.50Strike Price0.00Turnover82.24%IV27.82%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0597Delta0.0332Gamma171.80Leverage Ratio-0.0086Theta-0.0007Rho-10.26Eff Leverage0.0052Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet